The backbone of Venture Café – come meet the community and make connections with all different kinds of innovators. How will you make your serendipitous moment come true?
This session explores the future of biotech through the story of a problem uncovered in real lab environments: the growing disconnect between how experiments happen and how they’re documented. We’ll trace how firsthand frustrations with manual data entry and traditional Electronic Lab Notebooks (ELNs) revealed hidden costs in time, reproducibility, and insight—and why those limitations could no longer be ignored. From that discovery emerged a new approach to lab workflows. We’ll unpack how real-time experiment capture and AI-driven data structuring can sit on top of existing ELNs to reduce documentation burden and unlock deeper downstream analysis. Along the way, we’ll separate AI hype from reality, sharing practical insights into what AI-enhanced labs can do today—and how tools like Dimenso are helping teams move toward more efficient, reproducible, and truly AI-native lab environments.
What does it take to transform breakthrough research into companies that shape global industries? Join leading founders, investors, and innovation leaders for a conversation on how deep-tech discoveries move from the lab into scalable ventures that attract capital, build markets, and deliver real-world impact. This curated panel—hosted by One Way Ventures in partnership with Korea Institute of Science and Technology—brings together voices from academia, venture creation, and industry to explore the path from scientific discovery to global enterprise. Expect insights into commercialization, venture building, and the global partnerships required to scale deep-tech innovation.
This session will welcome a curated international audience of venture investors, banks, government representatives, and deep-tech founders visiting from across the U.S. and Asia.
Featuring:
- Prof. Yet-Ming Chiang (MIT) — Serial entrepreneur whose ventures, including A123 Systems and Form Energy, have collectively raised ~$2.5B
- Seonghoon Woo (Founder & CEO, Amogy) — MIT PhD; building an ammonia-to-power platform company that has raised $300M+
- Johannes Fruehauf (Founder & CEO, BioLabs; Chairman, LabCentral)
- Jaspaul Paul Singh (Co-Founder & CEO, Interon) — KIST-sponsored biotech founder
The backbone of Venture Café – come meet the community and make connections with all different kinds of innovators. How will you make your serendipitous moment come true?
This session explores the future of biotech through the story of a problem uncovered in real lab environments: the growing disconnect between how experiments happen and how they’re documented. We’ll trace how firsthand frustrations with manual data entry and traditional Electronic Lab Notebooks (ELNs) revealed hidden costs in time, reproducibility, and insight—and why those limitations could no longer be ignored. From that discovery emerged a new approach to lab workflows. We’ll unpack how real-time experiment capture and AI-driven data structuring can sit on top of existing ELNs to reduce documentation burden and unlock deeper downstream analysis. Along the way, we’ll separate AI hype from reality, sharing practical insights into what AI-enhanced labs can do today—and how tools like Dimenso are helping teams move toward more efficient, reproducible, and truly AI-native lab environments.
What does it take to transform breakthrough research into companies that shape global industries? Join leading founders, investors, and innovation leaders for a conversation on how deep-tech discoveries move from the lab into scalable ventures that attract capital, build markets, and deliver real-world impact. This curated panel—hosted by One Way Ventures in partnership with Korea Institute of Science and Technology—brings together voices from academia, venture creation, and industry to explore the path from scientific discovery to global enterprise. Expect insights into commercialization, venture building, and the global partnerships required to scale deep-tech innovation.
This session will welcome a curated international audience of venture investors, banks, government representatives, and deep-tech founders visiting from across the U.S. and Asia.
Featuring:
- Prof. Yet-Ming Chiang (MIT) — Serial entrepreneur whose ventures, including A123 Systems and Form Energy, have collectively raised ~$2.5B
- Seonghoon Woo (Founder & CEO, Amogy) — MIT PhD; building an ammonia-to-power platform company that has raised $300M+
- Johannes Fruehauf (Founder & CEO, BioLabs; Chairman, LabCentral)
- Jaspaul Paul Singh (Co-Founder & CEO, Interon) — KIST-sponsored biotech founder